FR2349330A1 - Composition destinee au traitement des hyperlipidemies - Google Patents

Composition destinee au traitement des hyperlipidemies

Info

Publication number
FR2349330A1
FR2349330A1 FR7612708A FR7612708A FR2349330A1 FR 2349330 A1 FR2349330 A1 FR 2349330A1 FR 7612708 A FR7612708 A FR 7612708A FR 7612708 A FR7612708 A FR 7612708A FR 2349330 A1 FR2349330 A1 FR 2349330A1
Authority
FR
France
Prior art keywords
pyridoxine
tocopherol
compsns
antioxidant
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7612708A
Other languages
English (en)
Other versions
FR2349330B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAVINI EMILE
Original Assignee
SAVINI EMILE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAVINI EMILE filed Critical SAVINI EMILE
Priority to FR7612708A priority Critical patent/FR2349330A1/fr
Publication of FR2349330A1 publication Critical patent/FR2349330A1/fr
Application granted granted Critical
Publication of FR2349330B1 publication Critical patent/FR2349330B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
FR7612708A 1976-04-29 1976-04-29 Composition destinee au traitement des hyperlipidemies Granted FR2349330A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7612708A FR2349330A1 (fr) 1976-04-29 1976-04-29 Composition destinee au traitement des hyperlipidemies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7612708A FR2349330A1 (fr) 1976-04-29 1976-04-29 Composition destinee au traitement des hyperlipidemies

Publications (2)

Publication Number Publication Date
FR2349330A1 true FR2349330A1 (fr) 1977-11-25
FR2349330B1 FR2349330B1 (fr) 1978-08-25

Family

ID=9172447

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7612708A Granted FR2349330A1 (fr) 1976-04-29 1976-04-29 Composition destinee au traitement des hyperlipidemies

Country Status (1)

Country Link
FR (1) FR2349330A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
WO2000021516A2 (fr) * 1998-10-14 2000-04-20 Kansas University Medical Center Research Institute, Inc. Procedes destines a empecher des complications diabetiques
WO2000023063A2 (fr) * 1998-10-22 2000-04-27 University Of South Carolina Procedes pour inhiber les complications diabetiques
US6472400B1 (en) 1995-09-12 2002-10-29 University Of Kansas Medical Center Advanced gylcation end-product intermediaries and post-Amadori inhibition
US6472411B1 (en) 1995-09-12 2002-10-29 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
EP1841436A1 (fr) * 2005-01-05 2007-10-10 Medicure International Inc. Composes et techniques de regulation des niveaux de triglyceride
US8003615B2 (en) * 2003-10-01 2011-08-23 Daiichi Fine Chemical Co., Ltd. Stable vitamin B6 derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROTE LISTE, 1961 "CARTIN") *
ROTE LISTE, 1961. "SKLEROBION MERCK" *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A3 (en) * 1987-02-18 1989-06-14 Ulrich Dr. Speck Use of pyridoxine derivatives in the prophylaxis and treatment of hyperlipemia and atherosclerosis
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6472400B1 (en) 1995-09-12 2002-10-29 University Of Kansas Medical Center Advanced gylcation end-product intermediaries and post-Amadori inhibition
US6472411B1 (en) 1995-09-12 2002-10-29 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
WO2000021516A2 (fr) * 1998-10-14 2000-04-20 Kansas University Medical Center Research Institute, Inc. Procedes destines a empecher des complications diabetiques
WO2000021516A3 (fr) * 1998-10-14 2001-01-04 Kansas University Medical Ct R Procedes destines a empecher des complications diabetiques
WO2000023063A3 (fr) * 1998-10-22 2000-07-13 Univ South Carolina Procedes pour inhiber les complications diabetiques
AU762030B2 (en) * 1998-10-22 2003-06-19 Kansas University Medical Center Research Institute, Inc. Methods for inhibiting diabetic complications
WO2000023063A2 (fr) * 1998-10-22 2000-04-27 University Of South Carolina Procedes pour inhiber les complications diabetiques
US8003615B2 (en) * 2003-10-01 2011-08-23 Daiichi Fine Chemical Co., Ltd. Stable vitamin B6 derivative
EP1841436A1 (fr) * 2005-01-05 2007-10-10 Medicure International Inc. Composes et techniques de regulation des niveaux de triglyceride
EP1841436A4 (fr) * 2005-01-05 2008-02-20 Medicure Int Inc Composes et techniques de regulation des niveaux de triglyceride

Also Published As

Publication number Publication date
FR2349330B1 (fr) 1978-08-25

Similar Documents

Publication Publication Date Title
FR2349330A1 (fr) Composition destinee au traitement des hyperlipidemies
CA1027528A (fr) Methode et machine d'emballage de copeaux de bois
HU896344D0 (en) Method for the treatment of leather by applying amphilyl copolymers
FI88579B (fi) Foerfarande foer framstaellning av en beredning med kontrollerad foersaettning av metoprolol
DE3853430D1 (de) Enzym-immunotestverfahren zum nachweis von hiv-antigenen in menschlichen seren.
ES1000263U (es) Aparato controlado y supervisado electronicamente para tratamiento tricologico segun vacio parcial variable del cuero cabelludo y tratamiento relacionado
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
ZA766753B (en) Method and composition for preventing nutritional deficiency
JPS5752495A (en) Operating method for treatment device and its controller and article treatment device
AU468674B2 (en) A spike for shoes and method for manufacturing thereof
EP0325129A3 (en) Disubstituted pyridines
CA927666A (en) Method and machine for treating soybeans
HK29284A (en) Threading device, and method of threading
CA961519A (en) Method and machine for conveying and aligning rod-shaped fasteners
EP0146065A3 (en) Improved betamethasone dipropionate cream
FR2323521A1 (fr) Procede et dispositif pour fabriquer des corps stratifies, notamment des semelles de chaussures a plusieurs couches
ES8600605A1 (es) Procedimiento para reducir el contenido de diterpenos de la esencia de cafe.
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
NO874694D0 (no) Begrenset inngangsmetode for samtidig indusering av flere frakturer i avviksbroenner.
CA1018868A (fr) Methode et materiel d'alignement des grumes
IL49943A (en) Method for reducing zearalenone
JPS51120093A (en) Dowel pin implanting machine and method
JPS5731858A (en) Method and device for continuously separating and supplying stacked piece of napkin, etc.
CA1001108A (en) Method of displacing a conveyor belt system in lateral fashion

Legal Events

Date Code Title Description
ST Notification of lapse